Molecular AF
- Product NDC
- 76348-401
- 11-digit product format
- 763480401
- Labeler code
- 76348
- Product ID
- 76348-401_2d3f2f5e-be56-71e9-e063-6294a90a6ac2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- tolnaftate
- Dosage form
- OIL
- Route
- TOPICAL
- Labeler
- Renu Laboratories, LLC
- Application
- M005
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2011-07-01
- Substance
- TOLNAFTATE
- Active strength
- .01 mg/mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 76348-401-02 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 76348-401-01 | U | Excluded because listing certification expired | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 76348-401-02 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 76348-401-01 | U | Excluded because listing certification expired | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 76348-401-02 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 76348-401-01 | U | Excluded because listing certification expired | 0efc9e666f02… | f202fb6c5f17… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 76348-401-02 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 76348-401-01 | I | Inactivated by FDA | 9bebd1f3094a… | 5416666fcb17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Molecular AF
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TOLNAFTATE | .01 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 06KB629TKV | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ebc62596-fc97-4d03-9483-7ba095d25db7 | Product name | 1 | 20151210 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 76348-401-01 | 2025-02-04 | MOLECULAR AF |
| 76348-401-02 | 2025-02-04 | MOLECULAR AF |
| 76348-401-01 | 2025-01-30 | MOLECULAR AF |
| 76348-401-02 | 2025-01-30 | MOLECULAR AF |
| 76348-401-01 | 2023-06-13 | MOLECULAR AF |
| 76348-401-02 | 2023-06-13 | MOLECULAR AF |
| 76348-401-01 | 2020-01-31 | MOLECULAR AF |
| 76348-401-02 | 2020-01-31 | MOLECULAR AF |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76348-401-01 | Molecular AF | 11.5 mL in 1 BOTTLE | OIL | 11.5 | 4 | |
| 76348-401-02 | Molecular AF | 11.5 mL in 1 BOX | OIL | 11.5 | 4 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| TOLNAFTATE | ACTIVE INGREDIENT | 06KB629TKV | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| TOLNAFTATE | ACTIVE MOIETY | 06KB629TKV | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| CINNAMON OIL | INACTIVE INGREDIENT | E5GY4I6YCZ | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| DIETHYLENE GLYCOL MONOETHYL ETHER | INACTIVE INGREDIENT | A1A1I8X02B | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| ETHYL MACADAMIATE | INACTIVE INGREDIENT | ANA2NCS6V1 | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| OLIVE OIL | INACTIVE INGREDIENT | 6UYK2W1W1E | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 | |
| TEA TREE OIL | INACTIVE INGREDIENT | VIF565UC2G | MOLECULAR AF (TOLNAFTATE) OIL [RENU LABORATORIES, INC.] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MICONAZOLE Nitrate 2% Cream ANTIFUNGAL | MICONAZOLE NITRATE | ASTONEA LABS PRIVATE LIMITED | e66191a6-0c3c-7319-e053-2a95a90aae84 | 2024-06-25 | Warnings | M005 |
| clotrimazole | CLOTRIMAZOLE | A-S Medication Solutions | b63a3fe5-5684-41bc-ad6c-69c54e5b942d | 2024-06-20 | Warnings | M005 |
| THERA Antifungal Body | MICONAZOLE NITRATE | McKesson Medical-Surgical Inc. | 31096041-28c9-4b16-bbd1-dbadefd37505 | 2024-06-14 | Warnings | M005 |
| Antifungal Body | MICONAZOLE NITRATE | McKesson | 4fb9aece-0baa-475e-e054-00144ff8d46c | 2024-06-13 | Warnings | M005 |
| Secura Protective | ZINC OXIDE | Smith & Nephew Medical Ltd | b077aa64-49a3-42ee-abb3-88f833635b93 | 2024-06-12 | Warnings | M005 |
| clotrimazole | CLOTRIMAZOLE | NuCare Pharmaceuticals,Inc. | 627375fb-2f20-16bc-e053-2a91aa0a1542 | 2024-06-06 | Warnings | M005 |
| Clotrimazole | CLOTRIMAZOLE | Cardinal Health 110 dba LEADER | 199df107-3384-6e03-e063-6294a90afc38 | 2024-05-29 | Warnings | M005 |
| Femmesil | CLOTRIMAZOLE | Aidance Skincare & Topical Solutions, LLC | efddad82-9dc7-4cd9-b33c-7e85f30d992e | 2024-05-24 | Warnings | M005 |
| Anti-Fungal | MICONAZOLE NITRATE | Universal Distribution Center LLC | 8f316b0d-d308-4ae6-82c4-39bb0d1d474e | 2024-05-21 | Warnings | M005 |
| CANESPIES | TOLNAFTATE | OPMX LLC | e2f9eedc-3c43-416b-85b5-ba07fb5fb4db | 2024-05-17 | Warnings | M005 |
| Up and Up Antifungal | TOLNAFTATE 1% | Target Corporation | 8f54c8c7-6771-49c3-b429-53aa6df54dc5 | 2024-05-08 | Warnings | M005 |
| Up and Up Athletes Foot | CLOTRIMAZOLE 1% | Target Corporation | 52b61859-11ae-4990-aa0c-9dc1dd00adf4 | 2024-05-08 | Warnings | M005 |
| ADI Medical PVP-I Pouch, Foil | POVIDONE-IODINE | Asia Dynamics Inc., d/b/a ADI Medical | 0e8baf24-0c67-5511-e063-6394a90acaa1 | 2024-05-02 | Warnings | M005 |
| Caseys Antimicrobial Hand Sanitizer | ETHYL ALCOHOL | Navajo Manufacturing Company Inc. | 78863024-390c-4ff9-8ed6-02af07902a30 | 2024-04-29 | Warnings | M005 |
| MQUPIN Liquid Fungal Nail Treatment | LIQUID FUNGAL NAIL TREATMENT | Zhengzhou Miaoqi Medical Technology Co., Ltd. | 14782f8c-3b29-1d88-e063-6294a90ac3e4 | 2024-03-25 | Warnings | M005 |
| ETADERM Advanced Antifungal Support | UNDECYLENIC ACID | NUEPHASE LLC | adb12a1c-ece9-4a59-a62c-89d212c57e6f | 2024-03-13 | Warnings | M005 |
| Dermachange Jock | MICONAZOLE NITRATE | Private label Beauty and Wellness | 12eef049-76c9-1450-e063-6394a90a00ea | 2024-03-05 | Warnings | M005 |
| Clotrimazole Antifungal | CLOTRIMAZOLE | Trifecta Pharmaceuticals USA, LLC. | 11bf50db-552e-0a39-e063-6394a90af60d | 2024-02-19 | Warnings | M005 |
| TOLNAFTATE ANTIFUNGAL | TOLNAFTATE | Bryant Ranch Prepack | fbbd159c-217e-46d3-963c-ba0bd1e9bbe8 | 2024-01-29 | Warnings | M005 |
| Target Jock Itch | CLOTRIMAZOLE 1% | Target Corporation | f44d4c44-99d1-413f-b9c3-8330bdd21abb | 2024-01-17 | Warnings | M005 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1362942 | Molecular AF 1 % Antifungal Topical Oil | PSN | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362937 | tolnaftate 1 % Topical Oil | PSN | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362942 | tolnaftate 10 MG/ML Topical Oil [Molecular AF] | SBD | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362937 | tolnaftate 10 MG/ML Topical Oil | SCD | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362942 | Molecular AF 1 % Topical Oil | SY | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362942 | Molecular AF 10 MG/ML Topical Oil | SY | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
| 1362937 | tolnaftate 1 % Topical Oil | SY | 1b47e687-29cf-48ce-8bc3-ac8f44f05baa | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 76348-401-01 | 76348040101 | 11.5 mL in 1 BOTTLE (76348-401-01) | 11.5 ml | 2011-07-01 | No | No | Current |
| 76348-401-02 | 76348040102 | 11.5 mL in 1 BOX (76348-401-02) | 11.5 ml | 2011-07-01 | No | No | Current |